Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 15, 2001Journal of Clinical Oncology

Phase I/II Study of the P-Glycoprotein Modulator PSC 833 in Patients With Acute Myeloid Leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

RDR T DorrFox Chase Cancer CenterCKChatchada KaranesNational Marine Sanctuary FoundationCSCatherine SpierUniversity of Arizona

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dorr et al. (2001) studied this question.

synapsesocial.com/papers/6a6f37f7e5469ee92be03f13https://doi.org/10.1200/jco.2001.19.6.1589
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Overexpression of the MDRL gene in blast cells from patients with acute myelocytic leukemia is associated with decreased anthracycline accumulation that can be restored by cyclosporin‐A1990 · 133 citations
  2. 2Pharmacokinetics of Daunorubicin and Doxorubicin in Plasma and Leukemic Cells from Patients with Acute Nonlymphoblastic Leukemia1989 · 50 citations